Padnarsertib

Overview

Padnarsertib (KPT-9274) is an orally bioavailable, dual PAK4 / Nicotinamide phosphoribosyltransferase ( Nampt ) inhibitor, with IC 50 s of <100 nM and 120 nM, respectively.

Application

Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Signaling Pathways > Cytoskeleton | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Signaling Pathways > PAK | Products > Signaling Pathways > NAMPT

Product Information

• Catalog No.: HY-12793
• CAS No.: 1643913-93-2
• Molecular Formula: C35H29F3N4O3
• Molecular Weight: 610.63
• Purity: 99.58%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
• Solubility: 2.08 mg/mL (3.41 mM); Suspended solution; Need ultrasonic
• Availability: In-stock

Source

Original product source